Document is current
Any future updates will be listed below
-
Authors
Pham, Loc M.
Nanney, Andria B.
Hasting, Jordan
Rüedi-Bettschen, Daniela
Freeman, Kevin B.
Rowlett, James K. https://orcid.org/0000-0002-4077-5017
-
Funding
Funding for this research was provided by:
NIDA (DA011792, DA056209, DA0039167, DA059181, DA043204)
- License Information
-
More Information
Article History
Received: 4 June 2025
Accepted: 16 October 2025
First Online: 1 November 2025
Declarations
:
: Dr. Rowlett is the director of Impatia Therapeutics, LLC, and is holder of US Patent Application No. 12,233,070 B2 (Feb 25, 2025) for certain uses of TPA023B. The other authors have no conflicts of interest to disclose.
: All procedures followed the National Research Council’s Guide for Care and Use of Laboratory Animals (2011), and all procedures were approved by the University of Mississippi Medical Center’s Institutional Animal Care and Use Committee. All animal facilities were fully accredited by AAALAC International.
: Not applicable.
: Not applicable.
